These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30935014)

  • 1. CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling.
    Lai CJ; Lin CY; Liao WY; Hour TC; Wang HD; Chuu CP
    Cells; 2019 Mar; 8(4):. PubMed ID: 30935014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
    Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
    Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
    Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The miRNAs 203a/210-3p/5001-5p regulate the androgen/androgen receptor/YAP-induced migration in prostate cancer cells.
    Huo C; Kuo YY; Lin CY; Shiah SG; Li CY; Huang SP; Chen JK; Wang WC; Kung HJ; Chuu CP
    Cancer Med; 2024 Aug; 13(16):e70106. PubMed ID: 39149855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference.
    Fu YK; Wang BJ; Tseng JC; Huang SH; Lin CY; Kuo YY; Hour TC; Chuu CP
    J Biomed Sci; 2022 Feb; 29(1):16. PubMed ID: 35197069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
    Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
    J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Citron Rho-interacting serine/threonine kinase knockdown suppresses prostate cancer cell proliferation and metastasis by blocking Hippo-YAP pathway].
    Haiping C; Qi X; Dawei L; Qiang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Mar; 39(3):257-263. PubMed ID: 31068310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression.
    Yu S; Cai X; Wu C; Wu L; Wang Y; Liu Y; Yu Z; Qin S; Ma F; Thiery JP; Chen L
    Oncotarget; 2015 Feb; 6(5):2951-65. PubMed ID: 25605020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
    You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L
    Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling.
    Zhou Y; Shan T; Ding W; Hua Z; Shen Y; Lu Z; Chen B; Dai T
    J Cell Physiol; 2018 Aug; 233(8):5805-5814. PubMed ID: 29215734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspalathin-rich green Aspalathus linearis extract suppresses migration and invasion of human castration-resistant prostate cancer cells via inhibition of YAP signaling.
    Huang SH; Kao YH; Muller CJF; Joubert E; Chuu CP
    Phytomedicine; 2020 Apr; 69():153210. PubMed ID: 32217447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.
    Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted frizzled-related protein 5 suppresses aggressive phenotype and reverses docetaxel resistance in prostate cancer.
    Xu Q; Lü Z; Wang X; Zhu Q; Wu H
    J Investig Med; 2019 Aug; 67(6):1009-1017. PubMed ID: 30787036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer.
    Matsuda Y; Narita S; Nara T; Mingguo H; Sato H; Koizumi A; Kanda S; Numakura K; Saito M; Inoue T; Hiroshima Y; Nanjo H; Satoh S; Tsuchiya N; Habuchi T
    BMC Cancer; 2020 Apr; 20(1):302. PubMed ID: 32293349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 acts through RhoA to regulate YAP signaling.
    Zhang Y; Xia H; Ge X; Chen Q; Yuan D; Chen Q; Leng W; Chen L; Tang Q; Bi F
    Cell Signal; 2014 Nov; 26(11):2504-13. PubMed ID: 25101858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of netrin-1 by hypoxia contributes to the invasion and migration of prostate carcinoma cells by regulating YAP activity.
    Chen H; Chen Q; Luo Q
    Exp Cell Res; 2016 Dec; 349(2):302-309. PubMed ID: 27815019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer.
    Shen J; Cao B; Wang Y; Ma C; Zeng Z; Liu L; Li X; Tao D; Gong J; Xie D
    J Exp Clin Cancer Res; 2018 Jul; 37(1):175. PubMed ID: 30055645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
    Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
    Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway.
    Zeng H; Ortiz A; Shen PF; Cheng CJ; Lee YC; Yu G; Lin SC; Creighton CJ; Yu-Lee LY; Lin SH
    Oncotarget; 2017 Feb; 8(6):10145-10160. PubMed ID: 28052036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Mechanics-Induced Fibroblast Activation through CD44-RhoA-YAP Pathway Ameliorates Crystalline Silica-Induced Silicosis.
    Li S; Li C; Zhang Y; He X; Chen X; Zeng X; Liu F; Chen Y; Chen J
    Theranostics; 2019; 9(17):4993-5008. PubMed ID: 31410197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.